Glucocorticoid use may trigger secondary diabetes or exacerbate hyperglycemia in patients with diabetes mellitus (DM). Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of patients with type 2 diabetes. Few reports mention liraglutide as a treatment for steroid-induced DM (SIDM). Here, we report a patient with SIDM and multiple sclerosis, for whom switching to liraglutide combined with metformin therapy improved glucose levels and ameliorated the symptoms of insulin allergy. Liraglutide may be useful for treating SIDM with insulin allergy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236694 | PMC |
| http://dx.doi.org/10.18999/nagjms.83.2.343 | DOI Listing |
Publication Analysis
Top Keywords
insulin allergy
12
multiple sclerosis
8
liraglutide
5
liraglutide insulin
4
allergy patient
4
patient glucocorticoid-induced
4
diabetes
4
glucocorticoid-induced diabetes
4
diabetes multiple
4
sclerosis glucocorticoid
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!